Hence, the STING pathway may shape tumor microenvironment via multimodal proinflammatory axes, leading to tumor growth and metastases on one hand, and the necessity to implement multidrug therapies in conjunction with STING agonist on the other. The gene discussed is STING1; the disease is neoplasm.